Glaxo Loses Paxil Suit At Federal Circuit

Law360, New York (April 10, 2005, 12:00 AM EDT) -- In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has ruled in favor of Canadian generics maker Apotex in a patent infringement lawsuit over the best-selling antidepressant Paxil.

The court ruled in an “en banc” hearing that Apotex’ generic version would infringe one claim of Glaxo’s patent for the drug, but determined that the patent was invalid due to “inherent anticipation.”

The decision overturns an earlier determination by a panel of the U.S. Court of Appeals for the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.